TMC Life Sciences Berhad (KLSE:TMCLIFE)
Malaysia · Delayed Price · Currency is MYR 0.4450
+0.0050 (1.14%)
At close: Aug 28, 2026
TMC Life Sciences Berhad Financials Overview
Financials in millions MYR. Fiscal year is July - June.
Millions MYR. Fiscal year is Jul - Jun.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 393.03 | 393.03 | 345.63 | 346.42 | 311.56 | 243.77 |
Revenue Growth | 13.71% | 13.71% | -0.23% | 11.19% | 27.81% | 21.27% |
Gross Profit Gross Profit Growth | 135.42 | 135.42 | 109.67 | 138.02 | 126.06 | 87.88 |
Operating Income Operating Income Growth | 30.36 | 30.36 | 12.21 | 57.36 | 47.05 | 32.09 |
Net Income Net Income Growth | 17.38 | 17.38 | 3.61 | 40.65 | 39.26 | 41.39 |
Earnings Per Share EPS Growth | 0.01 | 0.01 | 0.00 | 0.02 | 0.02 | 0.02 |
EPS Growth | 381.98% | 381.98% | -91.13% | 3.71% | -5.31% | 104.85% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 115.06 | 115.06 | 111.64 | 191.13 | 168.69 | 143.14 |
Total Debt Total Debt Growth | 145.22 | 145.22 | 182.97 | 205.23 | 219.06 | 210.44 |
Net Cash (Debt) Net Cash Growth | -30.15 | -30.15 | -71.33 | -14.1 | -50.37 | -67.3 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.02 | -0.02 | -0.04 | -0.01 | -0.03 | -0.04 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 57.69 | 57.69 | 22.51 | 74.76 | 54.57 | 35.65 |
Capital Expenditures CapEx Growth | -13.73 | -13.73 | -40.71 | -25.35 | -31.96 | -67.69 |
Free Cash Flow Free Cash Flow Growth | 43.96 | 43.96 | -18.2 | 49.41 | 22.61 | -32.04 |
Free Cash Flow Growth | - | - | - | 118.56% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 34.46% | 34.46% | 31.73% | 39.84% | 40.46% | 36.05% |
Operating Margin | 7.72% | 7.72% | 3.53% | 16.56% | 15.10% | 13.16% |
Pretax Margin | 6.55% | 6.55% | 2.05% | 15.19% | 13.12% | 13.20% |
Profit Margin | 4.42% | 4.42% | 1.04% | 11.73% | 12.60% | 16.98% |
FCF Margin | 11.19% | 11.19% | -5.27% | 14.26% | 7.26% | -13.15% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.006 | 0.006 | 0.002 | 0.005 | 0.004 | 0.003 |
Dividend Per Share Growth | 209.68% | 209.34% | -61.96% | 16.65% | 51.97% | 24.74% |
Dividend Yield | 1.25% | 1.28% | 0.43% | 0.78% | 0.74% | 0.58% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 1, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 44.60 | 45.10 | 207.71 | 28.28 | 26.62 | 21.46 |
Forward PE | - | 70.00 | 70.00 | 70.00 | 70.00 | 70.00 |
P/FCF Ratio | 17.63 | 17.83 | - | 23.27 | 46.23 | - |
PS Ratio | 1.97 | 1.99 | 2.17 | 3.32 | 3.36 | 3.64 |